Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) Peptid
CLN8
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN5612935
-
-
Target
Alle CLN8 Produkte
-
CLN8
(Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Quelle
-
Synthetic
-
Applikation
-
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
Sequenz
-
VFGVQSTAAG LWALLGDPVL HADKARGQQN WCWFHITTAT GFFCFENVAV
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CLN8 antibody, catalog no. 70R-7115
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Lyophilized
-
Buffer
-
Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
-
Target
-
CLN8
(Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
Synonyme
-
mnd Peptide, C8orf61 Peptide, EPMR Peptide, CLN8, transmembrane ER and ERGIC protein Peptide, ceroid-lipofuscinosis, neuronal 8 Peptide, CLN8 Peptide, Cln8 Peptide
-
Sie sind hier:
-
Startseite
-
Peptide
-
CLN8
-
Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8) Peptid (ABIN5612935)